For: | Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol 2021; 27(43): 7546-7562 [PMID: 34887648 DOI: 10.3748/wjg.v27.i43.7546] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i43/7546.htm |
Number | Citing Articles |
1 |
Saade Abdalkareem Jasim, Omar dheyauldeen salahdin, H. Malathi, Neha Sharma, Safia Obaidur Rab, Zafar Aminov, Atreyi Pramanik, Israa Hussein Mohammed, Mohammed Abed Jawad, Benien C. Gabel. Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA). Cell Biochemistry and Biophysics 2024; 82(4): 3031 doi: 10.1007/s12013-024-01423-5
|
2 |
Tasfik Ul Haque Pronoy, Sharmin Aktar, Kazi Soha, Md. Arifur Rahman, Md. Nurujjaman, Farhadul Islam. Head and Neck Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 12: 63 doi: 10.1007/16833_2022_97
|
3 |
Indy Bui, Stavroula Baritaki, Massimo Libra, Apostolos Zaravinos, Benjamin Bonavida. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications. Antioxidants & Redox Signaling 2023; 39(13-15): 853 doi: 10.1089/ars.2023.0250
|
4 |
Yuma Hane, Takahiro Tsuchikawa, Toru Nakamura, Kanako C. Hatanaka, Katsunori Sasaki, Noriko Kawai, Shintaro Takeuchi, Kimitaka Tanaka, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Toshiaki Shichinohe, Yutaka Hatanaka, Yoshihiko Hirohshi, Toshihiko Torigoe, Satoshi Hirano. Survivin as a Therapeutic Target for Neuroendocrine Neoplasms. Neuroendocrinology 2025; 115(3-4): 295 doi: 10.1159/000543270
|
5 |
Divya Janjua, Apoorva Chaudhary, Udit Joshi, Tanya Tripathi, Alok Chandra Bharti. Circulating tumor cells in solid malignancies: From advanced isolation technologies to biological understanding and clinical relevance in early diagnosis and prognosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(1): 189236 doi: 10.1016/j.bbcan.2024.189236
|
6 |
Qi Yan, Yuan-song Sun, Ran An, Fang Liu, Qi Fang, Zhen Wang, Tao Xu, Lijian Chen, Jian Du. Application and progress of the detection technologies in hepatocellular carcinoma. Genes & Diseases 2023; 10(5): 1857 doi: 10.1016/j.gendis.2022.04.003
|
7 |
Susanne B. Haga. Principles of Gender-Specific Medicine. 2023; : 513 doi: 10.1016/B978-0-323-88534-8.00020-1
|
8 |
Ruoxuan Liu, Jie Ouyang, Yinyi Gao, Bingyu Wang, Liming Li, Yi Geng, Jiewen Guo. Antiproliferative and apoptotic effects of strychnine in human hepatoma HepG2 cells and its mechanism. Materials Express 2023; 13(4): 598 doi: 10.1166/mex.2023.2394
|
9 |
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, Hashem O. Alsaab. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA. Cell Biochemistry and Biophysics 2024; 82(3): 1947 doi: 10.1007/s12013-024-01395-6
|
10 |
Vijayata Singh, Subhajit Pathak, Narendra Kumar, Giridhara R. Jayandharan. Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma. ACS Omega 2024; 9(28): 30945 doi: 10.1021/acsomega.4c03949
|